课题基金 / 基金详情

Interpretable Deep Learning to Unlock the Potential of Clinical RNA Sequencing for Precision Oncology Research

Interpretable Deep Learning to Unlock the Potential of Clinical RNA Sequencing for Precision Oncology Research
可解释的深度学习释放临床 RNA 测序在精准肿瘤学研究中的潜力
批准号:
408183
负责人:
Smirnov Petr
金额:
$7.65万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-10-01 至 2021-10-01

项目摘要

项目成果

Smirnov Petr的其他基金

相似基金

相关文献

中文摘要
翻译
当一个病人的标准癌症治疗失败时,肿瘤学家面临着从几十种治疗方法中选择一种的难题。目前的临床试验正在研究肿瘤的DNA测序是否可以为治疗的选择提供信息,但对于50%以上的患者来说,
英文摘要
When a patient fails standard cancer therapy, the oncologist is faced with the conundrum of selecting one of dozens of treatments. Present clinical trials are investigating whether DNA sequencing of tumors can inform the choice of treatment, but for 50+%
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of a Meta-Analytic Framework for Identification of Robust and Reproducible Genomic Predictors of Response to Cancer Therapy
Improving Genomic Predictors of Drug Response through Meta-Analysis of Large Pharmacogenomic Datasets
  • 批准号:
    367350
  • 项目类别:
    Studentship Programs
  • 资助金额:
    $1.27万
  • 财政年份:
    2016
  • 负责人:
    Smirnov Petr
  • 依托单位:
Improving Genomic Predictors of Drug Response through Meta-Analysis of Large Pharmacogenomic Datasets
海外基金